Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Am Pharm Assoc (2003) ; 63(3): 863-872, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36870937

RESUMO

BACKGROUND: West Virginia (WV) has been at the forefront of the opioid crisis in the United States, with the highest rate of opioid overdose mortality involving prescription opioids in the country. To curb the crisis, the state government implemented a restrictive opioid prescribing law in March 2018, Senate Bill 273 (SB273), to decrease opioid prescribing. However, sweeping changes in opioid policy can have downstream effects on stakeholders such as pharmacists. This study is part of a sequential mixed methods investigation of the impact of SB273 in WV in which we interviewed various stakeholders-including pharmacists-about the impact of the law. OBJECTIVES: This paper aims to explore how pharmacy practice during the opioid crisis impacted the need for restrictive legislation and how SB273 impacted subsequent pharmacy practice in WV. METHODS: Semi-structured interviews were conducted with 10 pharmacists who were practicing in counties that had been designated as high-prescribing counties based upon county-level prescribing/dispensing data from state records. Analysis of the interviews was informed by the methodological orientation of content analysis to identify emerging themes. RESULTS: Participants described confronting questionable opioid prescriptions, treatment costs, and insurance coverage driving opioids as a first-line choice for pain management, as well as the influence of corporate policies and the immense responsibility of being the "last line of defense" in the opioid crisis. A central impediment to the care of patients was the inability of the pharmacists to effectively communicate their concerns to prescribers, making improved prescriber-dispenser communication an essential next step in minimizing opioid care gaps. CONCLUSION: This is one of few qualitative studies that have explored pharmacists' experiences, perceptions, and role in the opioid crisis leading up to and during the enactment of a restrictive opioid prescribing law. In light of the difficulties they faced, a restrictive opioid prescribing law was viewed positively by pharmacists.


Assuntos
Analgésicos Opioides , Farmacêuticos , Humanos , Estados Unidos , Analgésicos Opioides/efeitos adversos , West Virginia , Epidemia de Opioides , Padrões de Prática Médica
2.
J Am Pharm Assoc (2003) ; 62(4): 1430-1437, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35461778

RESUMO

BACKGROUND: Previous large-scale vaccination clinics have been successful before the coronavirus disease 2019 (COVID-19) pandemic; however, owing to the strict storage requirements and pharmaceutical preparation needed for the COVID-19 vaccines, careful thought and planning were necessary to successfully deploy these clinics immediately after vaccine availability. The focus of this manuscript is to describe the development and implementation of COVID-19 vaccination clinics in a large public university, using professionals from within and outside of its health sciences schools. OBJECTIVES: The primary objective of this project was to (1) implement COVID-19 vaccination clinics for university faculty, staff, students, and community members. Additional objectives of the clinics were to (2) actively incorporate pharmacy, nursing, and medical students into the clinic workflow; (3) promote interprofessional collaboration among faculty and students; and (4) assess patient satisfaction. PRACTICE DESCRIPTION: The School of Pharmacy faculty, in conjunction with the Office of Strategic Initiatives, planned and coordinated COVID-19 vaccination clinics from December 2020 to July 2021. Students and faculty from schools of pharmacy, nursing, and medicine were used. COVID-19 vaccinations were offered to university faculty, staff, and students and community members based on the Centers for Disease Control and Prevention priority groups. The clinic processes were designed such that they could be scaled from 100 to 2,000 participants per day. PRACTICE INNOVATION: The School of Pharmacy led approach was adjustable depending on the number of patients, continuously monitored and adaptable. The importance of pharmacists as part of the interprofessional health care team was exemplified by faculty and students involved. EVALUATION METHODS: All patients receiving COVID-19 vaccinations at the clinics were e-mailed anonymous surveys for assessment of the quality of the vaccination encounter after completion of their primary vaccine series. RESULTS: More than 15,000 COVID-19 vaccinations were provided through the clinics from December 2020 to July 2021. Professional staffing totaled 3352 hours for the 48 clinics. Thirty-eight percent of the vaccinated patients responded to the clinic satisfaction survey with predominately excellent ratings. CONCLUSION: COVID-19 vaccination clinics can be successfully planned and implemented in a scalable fashion in a large university setting using an interprofessional team approach.


Assuntos
COVID-19 , Assistência Farmacêutica , COVID-19/prevenção & controle , Vacinas contra COVID-19 , Humanos , Farmacêuticos , Universidades , Vacinação
3.
Innov Pharm ; 13(3)2022.
Artigo em Inglês | MEDLINE | ID: mdl-36627909

RESUMO

Background: The CDC has issued interim guidance on administering influenza vaccines amidst the COVID-19 pandemic including providing specific appointment times. A large chain pharmacy has adopted this guidance and is encouraging patients to make appointments rather than a walk-in visit for the influenza vaccination to help avoid large crowds. Objective(s): This study aims to determine the impact of the COVID-19 pandemic on influenza vaccination rates (2019 versus 2020 season) and patient appointments versus walk-in visits. The second goal of this study is to evaluate patient satisfaction with the influenza vaccination process. Methods: Influenza vaccine data was collected from the chain pharmacy online database from the first week in September to the last week in December during 2019 to 2020 and from 2020 to 2021. The second part of this study included a voluntary survey to be completed by the patient regarding satisfaction and thoughts about the 2020-2021 influenza vaccination process. Results: The six stores identified showed an overall 7.6% increase in influenza vaccination rates from the 2019-2020 season to the 2020-2021 season (p-value= 0.73). There were a total of 15 survey respondents amongst the stores of which 100% of the patients were at least slightly comfortable with the vaccination process and very satisfied overall. Conclusion: The six pharmacy locations within a large chain revealed that COVID-19 had a positive impact on influenza vaccination rates. Although these results were not statistically significant, this study sets the framework for future vaccination studies.

4.
Am J Pharm Educ ; 72(5): 119, 2008 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-19214273

RESUMO

OBJECTIVE: To create and implement a compounding laboratory exercise utilizing a variety of techniques and equipment. DESIGN: A 3-hour laboratory exercise on preparing compound prescriptions for capsules was developed and taught to first-year doctor of pharmacy (PharmD) students. Students completed appropriate preparations and calculation of ingredients and prepared capsules using a hand-packing technique and a capsule-filling machine. The students then individually weighed the capsules and performed batch testing for uniformity. ASSESSMENT: Ninety-six percent of the students who completed the laboratory performed the necessary calculations for machine-prepared capsules correctly and 100% completed the calculations for the hand-filled capsules correctly. With the hand-filled capsules, 100% of the students processed all 4 units within +/-5% of the stated capsule weight and capsules were deemed successful and accurate. CONCLUSION: Students acquired a firm grasp of basic compounding techniques and the skills to prepare accurate, safe, and uniform dosage forms for patients.


Assuntos
Cápsulas , Composição de Medicamentos/métodos , Educação em Farmácia/métodos , Estudantes de Farmácia , Ensino/métodos , Química Farmacêutica/educação , Currículo , Composição de Medicamentos/normas , Educação em Farmácia/normas , Avaliação Educacional/métodos , Avaliação Educacional/normas , Humanos , Laboratórios , Controle de Qualidade , Faculdades de Farmácia , Pesos e Medidas/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA